Searched for
CLINICAL TRIALS IN INDIA
India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...- Stocks in news: M&M, BHEL, Adani Enterprises, Wipro, Tata Steel, Siemens and Divi's LabsIndian equity markets ended marginally lower on Sunday, breaking a seven-session winning streak. The NSE Nifty 50 decreased by 44 points, c...
- 'Liquid biopsy can ease financial burden for cancer patients': Scientists on how a $1,000 test could save $10,000 in treatment costsLiquid biopsy, a blood-based test that detects and analyses cancer-related biomarkers, is gaining ground as a tool to monitor disease progr...
- The man behind Lord’s Mark: Dr. Sachidanand Upadhyay features in TIME Magazine for the third consecutive yearDr. Sachidanand Upadhyay has gained recognition from TIME Magazine for his remarkable contributions to technology and innovation. Lord’s Ma...
- With most drug candidates failing in humans, India’s draft rules bet on the wrong science in animal lab testingRecent draft rules in India threaten advancements in non-animal testing for drug development and safety. The new regulations may prioritize...
- India leads on non-animal testing and its draft lab animal rules threaten to undo thatIndia's draft Prevention of Cruelty to Animals Rules 2026 proposes significant changes to animal research regulations and oversight. It all...
- His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccinesHyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technol...
- Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology se...
- Hospital balance sheet: How AI could cut costs and improve efficiencyAs hospitals grapple with soaring costs in drugs, supplies, and labor, the integration of AI emerges as a vital necessity.
- QClairvoyance's quantum chemistry bet: Transitioning from research to pharma partnershipsQClairvoyance Quantum Labs has performed chemically precise simulations of eight small molecules on an actual quantum computer, marking pro...
- Kirana stores make room for new generation FMCG brands as they muscle past legacy giantsIndia's kirana market has seen new-age consumer brands expand their market share to nearly 22%. This increase has impacted the dominance of...
- AI halves drug discovery times, but =trial bottleneck remains a costly realityNovo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory a...
- Don't stunt the stent, med devices sectorThree coronary stent models from Meril Life Sciences were withdrawn from the Sri Lankan market due to performance issues. The National Medi...
- Have you been told you have prediabetes? A 12-week study found a surprising blood sugar benefit from lifting weights twice a weekA 12-week strength-training programme helped 34% of participants with prediabetes return to normal blood glucose levels, according to a cli...
- Aromatherapy: Can essential oils really help with stress, sleep and headaches?Essential oils have gained popularity for their potential wellness benefits. Studies suggest that aromatherapy may reduce stress and improv...
- Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and developmentThe Ministry of Science has entered into a partnership with Peptris Technologies to bolster drug development under the initiative called VI...
- Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...
- Our central mission must be patient-centric innovation: JP NaddaJ P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural coho...
- Pills, gels and implants: Men may get more contraceptives options as WHO floats new guidelinesIn an effort to widen the landscape of male contraceptive options, the World Health Organization has released new global guidelines. These ...
- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
Load More
